PALLEIKO BENJAMIN L (CFO and Secretary) sold 0.2% of their position (1.04K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $15.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001366244-26-000003
Officer· CFO and Secretary
Since Sep 2018
-1.04K
Net shares
Net seller
$15.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.42K acquired · 3.46K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.42K
Price / share
—
Trade value
—
% of position
0.6%
2/17/2026
428.29K→430.70K
Common Stock
Direct
Shares
−1.04K
Price / share
$15.00
Trade value
$15.57K
% of position
0.2%
2/18/2026
430.70K→429.67K
Total
Net shares
+1.38K
Net value
-$15.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | M · Option Exercise | +2.42K | — | — | 0.6% | 428.29K | 430.70K |
| Common Stock Direct | 2/18/2026 | S · Sale | −1.04K | $15.00 | $15.57K | 0.2% | 430.70K | 429.67K |
| Total | +1.38K | -$15.57K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
2.42K shares
Shares
−2.42K
Strike price
Held after
2.42K
Exercisable
—
2/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock2.42K shares | 2/17/2026 | M · Option Exercise | −2.42K | — | 2.42K |